Header cover image

Spanish (IBEX) Healthcare Sector Analysis

UpdatedJan 31, 2025
DataAggregated Company Financials
Companies14
  • 7D2.6%
  • 3M-10.6%
  • 1Y2.9%
  • YTD-1.4%

The Healthcare industry is up 2.3% in the last week, with Almirall up 12%. Overall in the last year, the industry is flat. As for the next few years, earnings are expected to grow by 31% per annum.

Sector Valuation and Performance

Has the Spanish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 31 Jan 2025€14.7b€10.6b€392.4m20.3x37.3x1.4x
Sun, 29 Dec 2024€14.4b€10.6b€392.5m19.2x36.8x1.4x
Tue, 26 Nov 2024€15.5b€10.5b€393.8m19.5x39.3x1.5x
Thu, 24 Oct 2024€16.0b€10.2b€394.8m16x40.6x1.6x
Sat, 21 Sep 2024€15.1b€10.2b€399.9m14.9x37.7x1.5x
Mon, 19 Aug 2024€14.0b€10.2b€399.9m15.2x35.1x1.4x
Wed, 17 Jul 2024€15.3b€10.0b€405.9m20x37.7x1.5x
Fri, 14 Jun 2024€15.5b€10.0b€405.8m21.3x38.1x1.6x
Sun, 12 May 2024€14.9b€10.0b€266.6m18.5x55.8x1.5x
Tue, 09 Apr 2024€14.4b€10.0b€292.0m21.3x49.4x1.4x
Thu, 07 Mar 2024€12.5b€10.0b€289.0m21.3x43.2x1.3x
Sat, 03 Feb 2024€14.2b€10.0b€331.9m17.6x42.6x1.4x
Mon, 01 Jan 2024€17.2b€10.0b€332.6m17.3x51.6x1.7x
Wed, 29 Nov 2023€15.3b€10.0b€332.6m17.1x46.1x1.5x
Fri, 27 Oct 2023€13.2b€9.8b€302.1m17x43.6x1.3x
Sun, 24 Sep 2023€15.1b€9.8b€311.0m19.2x48.5x1.5x
Tue, 22 Aug 2023€15.4b€9.8b€311.0m19.4x49.5x1.6x
Thu, 20 Jul 2023€14.8b€9.6b€364.6m21.4x40.5x1.5x
Sat, 17 Jun 2023€13.5b€9.6b€364.6m20.8x36.9x1.4x
Mon, 15 May 2023€13.5b€9.3b€533.7m21.1x25.4x1.5x
Wed, 12 Apr 2023€12.5b€9.3b€563.7m18.5x22.1x1.3x
Fri, 10 Mar 2023€13.2b€9.3b€564.2m19.9x23.5x1.4x
Sun, 05 Feb 2023€15.5b€8.4b€430.6m13.8x36x1.9x
Tue, 03 Jan 2023€14.1b€8.4b€430.5m13.9x32.7x1.7x
Thu, 01 Dec 2022€13.7b€8.4b€431.4m14.5x31.6x1.6x
Sat, 29 Oct 2022€12.8b€8.4b€462.3m13.8x27.7x1.5x
Mon, 26 Sep 2022€13.4b€8.3b€461.7m13.7x29.1x1.6x
Wed, 24 Aug 2022€15.7b€8.3b€465.4m14.2x33.7x1.9x
Fri, 22 Jul 2022€18.7b€7.9b€514.2m14.6x36.4x2.4x
Sun, 19 Jun 2022€19.0b€7.9b€513.8m13.7x36.9x2.4x
Tue, 17 May 2022€20.6b€7.8b€485.6m14.4x42.4x2.6x
Thu, 14 Apr 2022€18.9b€7.8b€487.8m14.9x38.8x2.4x
Sat, 12 Mar 2022€19.1b€7.8b€506.8m13.5x37.6x2.5x
Mon, 07 Feb 2022€18.5b€7.9b€932.5m16.3x19.9x2.4x
Price to Earnings Ratio

19.9x


Total Market Cap: €18.5bTotal Earnings: €932.5mTotal Revenue: €7.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Healthcare Sector Price to Earnings3Y Average 37.8x202320242025
Current Industry PE
  • Investors are relatively neutral on the Spanish Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 37.7x.
  • The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 25% per year over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare sector?

ES Market3.50%
Healthcare2.58%
Pharma5.92%
Healthcare Services3.99%
Medical Equipment0.63%
Healthtech0%0
Biotech-0.52%
Life Sciences-1.13%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 49.5x.
    • Analysts are expecting annual earnings growth of 91.4%, which is higher than its past year's earnings growth of 14.9% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 91% over the next 5 years.
  • This is better than its past earnings growth rate of 15% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 22% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROVI Laboratorios Farmaceuticos Rovi€65.505.3%
+€168.8m
3.4%PE20.3x
ALM Almirall€9.518.4%
+€156.9m
12.6%PS2.1x
FAE Faes Farma€3.544.0%
+€42.0m
16.3%PE11.3x
CBAV Clínica Baviera€34.207.2%
+€36.8m
41.9%PE14.7x
PHM Pharma Mar€84.902.4%
+€34.8m
126.2%PE2375.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ORY

€1.43

Oryzon Genomics

7D

-0.1%

1Y

-24.1%

PHM

€84.90

Pharma Mar

7D

2.4%

1Y

126.2%

ROVI

€65.50

Laboratorios Farmaceuticos Rovi

7D

5.3%

1Y

3.4%

PANG

€1.75

Pangaea Oncology

7D

-1.1%

1Y

-5.4%

ALM

€9.51

Almirall

7D

8.4%

1Y

12.6%

GRF

€8.40

Grifols

7D

-1.3%

1Y

-16.5%

CBAV

€34.20

Clínica Baviera

7D

7.2%

1Y

41.9%

LAB

€2.88

Labiana Health

7D

-1.4%

1Y

125.0%

RJF

€2.66

Laboratorio Reig Jofre

7D

3.9%

1Y

10.8%

PRM

€9.66

Prim

7D

0.6%

1Y

-6.7%